U.S. Capital Wealth Advisors LLC Makes New $482,000 Investment in Oscar Health, Inc. $OSCR

Key Points

• U.S. Capital Wealth Advisors LLC made a new investment of $482,000 in Oscar Health, acquiring 22,500 shares during the 2nd quarter.
• Oscar Health's stock opened at $18.01 and has a market capitalization of $4.66 billion, with a 50-day moving average of $16.46.
• The company reported a quarterly revenue of $2.86 billion, up 29.0% from the previous year, despite a posted loss of ($0.89) earnings per share.

U.S. Capital Wealth Advisors LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,500 shares of the company's stock, valued at approximately $482,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Jones Financial Companies Lllp grew its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio bought a new stake in shares of Oscar Health during the 1st quarter worth $30,000. Larson Financial Group LLC lifted its holdings in shares of Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after acquiring an additional 2,512 shares during the last quarter. CWM LLC grew its position in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its stake in Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock valued at $45,000 after acquiring an additional 2,854 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of Oscar Health stock opened at $18.01 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $22.78. The business's 50 day simple moving average is $16.46 and its two-hundred day simple moving average is $15.33. The stock has a market capitalization of $4.66 billion, a P/E ratio of -22.24 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the prior year, the firm posted $0.20 earnings per share. The business's quarterly revenue was up 29.0% compared to the same quarter last year. Analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. UBS Group reissued a "sell" rating and set a $11.00 price objective (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Robert W. Baird reiterated a "neutral" rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Finally, Piper Sandler decreased their price target on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Four investment analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Strong Sell" and an average price target of $12.07.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the firm's stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider owned 501,148 shares of the company's stock, valued at $9,236,157.64. This trade represents a 44.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is currently owned by company insiders.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.